Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-12-08

Clinical Trial Update: Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicating a Phase 1/Phase 2 evaluation of fibrinogen concentrate (FGTW) in trauma patients presumed to bleed, with the study status marke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fibrinogen Concentrate (FGTW) (fibrinogen concentrate)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Trauma, Massive Hemorrhage | Phase 1, Phase 2 | Status: COMPLETED